Targeted Approach to Metastatic Colorectal Cancer: What Comes Beyond Epidermal Growth Factor Receptor Antibodies and Bevacizumab?

Therapeutic Advances in Medical Oncology - United States
doi 10.1177/1758834012462462
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

SAGE Publications


Related search